Benzinga - Gainers
- Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
- Boxlight Corporation (NASDAQ: BOXL) gained 39% to $0.55. Boxlight authorized repurchase program of up to $15 million in shares of Class A common stock.
- Blue Water Vaccines, Inc. (NASDAQ: BWV) shares rose 30.8% to $1.5299. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business development executive, as Senior Vice President of Marketing and Business Development.
- Iris Energy Limited (NASDAQ: IREN) gained 32% to $2.8199. Iris Energy said it is increasing its self-mining capacity from 2.0 EH/s to 5.5 EH/s.
- Rubius Therapeutics, Inc. (NASDAQ: RUBY) surged 24.2% to $0.2361.
- Recruiter.com Group, Inc. (NASDAQ: RCRT) gained 20.1% to $0.4802 after the company announced a ChatGPT course and upskilling platform.
- SkyWater Technology, Inc. (NASDAQ: SKYT) climbed 20.1% to $13.73 after the company posted better-than-expected Q4 results.
- Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) shares gained 19% to $4.32 after the company announced it will acquire the Phase 2 program for 225Ac-PSMA I&T, a radiopharmaceutical targeting metastatic castrate resistant prostate cancer.
- United Insurance Holdings Corp. (NASDAQ: UIHC) jumped 17.3% to $1.29.
- Palantir Technologies Inc. (NYSE: PLTR) rose 14.3% to $8.69 after the company reported better-than-expected fourth-quarter financial results. The company also issued first-quarter and FY23 guidance.
- Genius Brands International, Inc. (NASDAQ: GNUS) shares gained 12.8% to $4.06 after the company announced an exclusive deal with BuzzFeed.
- MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) surged 12.3% to $1.87.
- Secoo Holding Limited (NASDAQ: SECO) gained 11.7% to $3.15.
- Marathon Digital Holdings, Inc. (NASDAQ: MARA) surged 11.5% to $6.53.
- GeoVax Labs, Inc. (NASDAQ: GOVX) rose 11.3% to $0.8765.
- Opendoor Technologies Inc. (NASDAQ: OPEN) gained 10% to $2.2100. Citigroup maintained Opendoor Technologies with a Neutral and raised the price target from $1.5 to $2.
- Semantix, Inc. (NASDAQ: STIX) jumped 9.6% to $1.72.
- Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 9% to $ 0.2528.
- Avis Budget Group, Inc. (NASDAQ: CAR) jumped 8.9% to $240.18 after the company reported better-than-expected fourth-quarter financial results.
- Hyperfine, Inc. (NASDAQ: HYPR) gained 9% to $1.3400. Hyperfine announced FDA clearance for improved AI-powered software and expanded field of view for the swoop portable MR imaging system.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Top Ships Inc. (NASDAQ: TOPS) shares dropped 44.8% to $0.91. TOP Ships priced $13.6 million registered direct offering at $1.35 per unit.
- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) dipped 30.7% to $0.3657. Mobiquity Technologies reported pricing of $3.75 million public offering.
- IMV Inc. (NASDAQ: IMV) fell 27.8% to $0.9601. IMV announced preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut-S (MVP-S), in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) for relapsed, refractory Diffuse Large B Cell Lymphoma (r/r DLBCL).
- Soligenix, Inc. (NASDAQ: SNGX) fell 27.4% to $4.2428 after the company announced it received a refusal to file letter from the FDA for its HyBryte new drug application in the treatment of cutaneous T-Cell lymphoma.
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) declined 21.2% to $0.2028. Sorrento Therapeutics said its Scintilla Pharmaceuticals unit commenced voluntary proceedings under Chapter 11 of US bankruptcy code.
- Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) shares dropped 21.8% to $0.8601 after the company reported a proposed public offering of common stock.
- T2 Biosystems, Inc. (NASDAQ: TTOO) shares fell 21.4% to $75.65 after the company reported a proposed public offering and announced results upon completion of the U.S. clinical evaluation for the T2Biothreat Panel.
- Shift Technologies, Inc. (NASDAQ: SFT) dipped 20.8% to $0.22.
- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) dropped 17.7% to $3.5117. HC Wainwright & Co. reiterated Corbus Pharmaceuticals with a Buy and maintained a $3 price target.
- Aptinyx Inc. (NASDAQ: APTX) dropped 17.2% to $0.4606.
- Endava plc (NYSE: DAVA) fell 14.3% to $75.65 after the company posted Q2 results.
- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) dropped 14.2% to $6.09. China Jo-Jo Drugstores announced a $2.625 million registered direct offering.
- Titan Medical Inc. (NASDAQ: TMDI) fell 14% to $0.1635. Nasdaq notified Titan Medical regarding audit committee requirements.
- Athenex, Inc. (NASDAQ: ATNX) dropped 13.5% to $0.1893.
- VNET Group, Inc. (NASDAQ: VNET) shares fell 13.3% to $5.30.
- The GEO Group, Inc. (NYSE: GEO) declined 12.5% to $10.45 after the company issued FY23 EPS guidance below estimates.
- Cytek Biosciences, Inc. (NASDAQ: CTKB) dropped 12.5% to $11.38. DiaSorin's subsidiary Luminex Corporation will sell its Flow Cytometry & Imaging (FCI) business unit to Cytek Biosciences.
- Tellurian Inc. (NYSE: TELL) fell 12% to $1.5750. B of A Securities downgraded Tellurian from Buy to Underperform and lowered the price target from $4 to $1.5.
- Materialise NV (NASDAQ: MTLS) dropped 12% to $8.95 after the company posted a Q4 loss.
- ContextLogic Inc. (NASDAQ: WISH) fell 10.8% to $0.7822.
- MRC Global Inc. (NYSE: MRC) dropped 9.7% to $12.09 following weak quarterly sales.
- Outset Medical, Inc. (NASDAQ: OM) fell 9.6% to $25.72 after the company reported Q4 results and issued FY23 guidance.
- Guardforce AI Co., Limited (NASDAQ: GFAI) fell 7.8% to $14.29 after dropping 18% on Monday. Guardforce AI recently announced a 1-for-40 reverse split.
- Edible Garden AG Incorporated (NASDAQ: EDBL) fell 7% to $3.83 after dropping around 8% on Monday. Edible Garden recently announced pricing of an upsized $10.2 million underwritten public offering.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.